Matthew Harris

Biosketch / Results /

Matthew Harris

Professor, Department of Surgery
NYU Surgical Oncology Associates

Contact Info

212-731-5413
Matthew.Harris@nyumc.org

Education

— NYU Medical Center (Surgery) 1957-1958 and 1960-1963, Residency Training
— Chicago Medical School, Medical Education
1956-1957 — NYU Medical Center (Mixed), Internship

Research Keywords

Treatment of melanoma, breast cancer, skin cancer, Vaccine therapy for cancer

Changes in the presence of multiple markers of circulating melanoma cells correlate with clinical outcome in patients with melanoma
Reynolds, Sandra R; Albrecht, Jeff; Shapiro, Richard L; Roses, Daniel F; Harris, Matthew N; Conrad, Andrew; Zeleniuch-Jacquotte, Anne; Bystryn, Jean-Claude. Changes in the presence of multiple markers of circulating melanoma cells correlate with clinical outcome in patients with melanoma. Clinical cancer research. 2003 Apr ;9(4):1497-1502 (34746)

Vaccine-induced CD8+ T-cell responses to MAGE-3 correlate with clinical outcome in patients with melanoma
Reynolds, Sandra R; Zeleniuch-Jacquotte, Anne; Shapiro, Richard L; Roses, Daniel F; Harris, Matthew N; Johnston, Dean; Bystryn, Jean-Claude. Vaccine-induced CD8+ T-cell responses to MAGE-3 correlate with clinical outcome in patients with melanoma. Clinical cancer research. 2003 Feb ;9(2):657-662 (34747)

Assessment of hormone receptor status and HER2 expression by fine needle aspiration biopsy in breast cancer
Hussain, M; Cangiarella, J; Volm, M; Harris, MN; Roses, DF; Berman, RS. Assessment of hormone receptor status and HER2 expression by fine needle aspiration biopsy in breast cancer [Meeting Abstract]. Annals of surgical oncology. 2003 JAN ;10(1):S54-S55 (38553)

Hypo-Fractionated Conformal Radiation Therapy to the Tumor Bed After Segmental Mastectomy
Formenti, Silvia C; Roses, Daniel; Harris, Matthew; Shapiro, Richard; Guth, Amber. Hypo-Fractionated Conformal Radiation Therapy to the Tumor Bed After Segmental Mastectomy. [Ft. Belvoir, VA] : Ft. Belvoir Defense Technical Information Center, 2003 20 p. (2130)

Presence of Mab 465.12 defined cytoplasmic melanoma-associated antigen in sera of patients with melanoma and relation to prognosis
Levy, D; Reynolds, SR; Ferrone, S; Shapiro, RL; Harris, MN; Roses, DF; Bystryn, J. Presence of Mab 465.12 defined cytoplasmic melanoma-associated antigen in sera of patients with melanoma and relation to prognosis [Meeting Abstract]. Journal of investigative dermatology. 2002 JUL ;119(1):240-240 (55283)